Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...

Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration that would require Medicare and Medicaid to cover anti-obesity drugs, ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

When I tell people I direct clinical research studies, I often encounter surprise. “Aren’t you a physician?” they ask. It ...

Goodwill Industries of ETX in Longview is looking for an Assistant Manager to join their team. Visit this article to learn ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...

The Honkai Star Rail banner schedule is a handy resource for players to refer to, as it not only shows what current warp events are taking place and reveals the rewards available for taking part ...

BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.

These medications work by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1), which is released in the gut after eating and typically signals feelings of fullness. Mounjaro also ...